Txp Neph @WUNephrology Dir. Kidney Txp @stlouisva co-chair KDWG @clingenresource. AE @KidneyMed. Rsrch #complement #genetics #TMA #AMD #Preeclampsia RT#endorse
Missouri, USA
Joined March 2019
- Tweets8.9K
- Following798
- Followers3.5K
- Likes27.9K
Anuja Java, MD (she/her) retweeted
📍 Happening now at @ASNKidney KidneyWeek in Denver!
Join us for the ASN OncoNephrology Program for a day of cutting-edge science, emerging cancer therapies, and practical insights.
Are your ready? 🫘
@onconeph @rc_oncneph @SheronLatcha @ShrutiGkidney @PaulHannaMD @hhashmi87
Anuja Java, MD (she/her) retweeted
Don’t miss @anuja_java's presentation and panel at #KidneyWk 2026 Early Program!
Explore the full @WashUNephrology calendar: nephrology.wustl.edu/washu-n…
Anuja Java, MD (she/her) retweeted
Denver, here we come! Check out our 2026 ASN #KidneyWk @WashUNephrology calendar of presentations, posters, and more!
nephrology.wustl.edu/washu-n…
Anuja Java, MD (she/her) retweeted
How much kidney function is enough for the right dose?
This session by @PaulHannaMD and Thomas Nolin looks at individualising GFR assessment and multidisciplinary dose adjustment of anticancer therapies in CKD and ESKD.
@rc_oncneph @onconeph @SheronLatcha @ShrutiGkidney
Anuja Java, MD (she/her) retweeted
🩸Thrombotic Microangiopathy in Patients with Cancer 🩸
Cancer associated TMA can be complex, especially when complement activation is involved.
This session by @anuja_java will explore the role of complement regulation and inhibition in these patients.
@rc_oncneph @onconeph
Anuja Java, MD (she/her) retweeted
Our next session?
🩺Case Based Debates in Onconephrology ➡️ To Transplant or Not to Transplant in patients with cancers ?
Discussants : Nadia Al Haddad, @hhashmi87 @anuja_java @nymurakami @itunuowoyemi
Register 🔗: asn-online.org/education/kid…
@rc_oncneph @onconeph @SheronLatcha
Anuja Java, MD (she/her) retweeted
🦀🫘👩🏻⚕️Kidney Transplant Onconephrology
How do we approach cancer treatment in KTRs?
Dr Murakami @nymurakami discusses immunotherapy, engineered cellular therapies and management of PTLDs
Register 🔗 : asn-online.org/education/kid…
@onconeph @SheronLatcha @rc_oncneph @ShrutiGkidney
Anuja Java, MD (she/her) retweeted
✨Session 4: AKI and Electrolyte Disturbances in Cancer and Novel Targeted Therapies
Cancer therapies continue to evolve, and so do the kidney complications we see with them.
🎙️ : @ZiolkowskiSusan
@onconeph @SheronLatcha @MaulinPatelDO
Register : asn-online.org/education/kid…
Anuja Java, MD (she/her) retweeted
Next off, we discuss Novel Radioligand Therapies and Nephrotoxicity
This session by @rc_oncneph will focus on these newer therapies and an important question for nephrologists: what do we need to know about their renal effects?
@onconeph @SheronLatcha @ShrutiGkidney
Anuja Java, MD (she/her) retweeted
Explore Genetics in Kidney Care
The Genetics in Kidney Health Summit Recordings Showcase brings together established approaches, emerging research, and patient stories.
Watch on demand: vimeo.com/showcase/12432086
Anuja Java, MD (she/her) retweeted
Update on Paraproteinemia and Kidney Pathologies: Monoclonal vs. Monotypic
This session by Lihong Bu will look at monoclonal vs. monotypic patterns and the renal pathologies we need to recognise.
@onconeph @SheronLatcha @rc_oncneph @ShrutiGkidney
Anuja Java, MD (she/her) retweeted
Here’s the ASN Onconephrology Program at #KidneyWeek 2026 in Denver.
A full day covering new therapies, kidney complications of cancer treatment, transplant, pathology, immunotherapy, & case-based discussions.
Hope to see many of you there!
@onconeph @rc_oncneph @SheronLatcha
Anuja Java, MD (she/her) retweeted
Keep growing your clinical knowledge after #aHUS24Sept. 📈Join the Society of Critical Care Medicine (@SCCM) this Friday for a webcast on accelerating diagnosis and improving outcomes for atypical HUS & #TMA. 🗓️25 Sept 2026⏰ 10:00 - 11:00 AM CT #aHUS #CriticalCare #MedEd
Anuja Java, MD (she/her) retweeted
Keep growing your clinical knowledge after #aHUS24Sept. 📈Join the Society of Critical Care Medicine (@SCCM ) TODAY for a webcast on accelerating diagnosis and improving outcomes for atypical HUS & #TMA. 🗓️25 Sept 2026⏰ 10:00 - 11:00 AM CT #aHUS #CriticalCare #MedEd
Anuja Java, MD (she/her) retweeted
🔬 Diagnosing #aHUS remains a clinical challenge. Clinicians & researchers: Help others navigate complex aHUS diagnosis & care by sharing your work/insights with colleagues w/#aHUS24Sept. An expert review from @anuja_java on this complex #raredisease:
pmc.ncbi.nlm.nih.gov/article…
Anuja Java, MD (she/her) retweeted
👏Check out recent publications @WashUNephrology by @Myasirbaloch, @anuja_java, @HumphreysLab, Chenjian Gu, and Yili Fang (Maggie Chen Lab).
nephrology.wustl.edu/washu-n…
Anuja Java, MD (she/her) retweeted
ISN e-symposium today on genetic and clinical implications in aHUS management @anuja_java
@ISNkidneycare
@ISNeducation
#ThisIsISN
#ISNWebinar
Anuja Java, MD (she/her) retweeted
We are hiring a nephrologist at the Durham VA in North Carolina. I have been practicing here for 19 years and would love to have you join us in a wondefrful academic environment. See the job description attached or reach out to me if you are interested
usajobs.gov/job/885314900
Anuja Java, MD (she/her) retweeted
🧵 Cancer & Complementology with Anuja Java
A fascinating look at how complement can be both friend and foe in cancer, and why context matters so much.
@anuja_java @rc_oncneph @ShrutiGkidney @harvardmed @DanaFarber
Anuja Java, MD (she/her) retweeted
The last session ?
A case panel from Brigham and Women's and Dana-Farber, presented by Dr. Abdullah Jalal @AbdullahJalalMD with onconephrologists Meghan Sise (MGH), @ShrutiGkidney Shruti Gupta (BWH/DFCI), Ala Abudayyeh (MD Anderson) and Elad Sharon @EladSharonMD
@rc_oncneph
